Rajpura Asim, Wright Andrew C, Board Timothy N
The Centre for Hip Surgery, Wrightington Hospital, Wigan, Lancashire, UK.
Hip Int. 2011 Jul-Aug;21(4):385-92. doi: 10.5301/HIP.2011.8538.
Osteonecrosis or avascular necrosis (AVN) of the hip is a progressive disease mainly affecting adults in their third, fourth or fifth decade of life. Studies into the natural history of the disease suggest that femoral head collapse occurs within 2-3 yrs with associated degenerative changes and at that stage arthroplasty is the most reliable treatment option. Therefore prevention of femoral head collapse is highly desirable in this young patient group. In early stage disease, before femoral head collapse (Ficat and Arlet stage 1-3) core decompression of the femoral head is currently the most widely used procedure to try to relieve intraosseous pressure in the femoral head and restore blood supply.Greater understanding of the pathogenesis of osteonecrosis has led to research into non-surgical management of early stages of the disease, including pharmacological and biophysical treatments.There may be a reduction in symptoms and evidence of prevention of disease progression following some non-surgical treatments. Further studies are needed, including trials comparing medical management with surgical intervention.
髋关节骨坏死或缺血性坏死(AVN)是一种主要影响30至50岁成年人的进行性疾病。对该疾病自然史的研究表明,股骨头塌陷会在2至3年内发生,并伴有相关的退行性改变,在那个阶段,关节置换术是最可靠的治疗选择。因此,在这个年轻患者群体中,预防股骨头塌陷非常必要。在疾病早期,在股骨头塌陷之前(Ficat和Arlet 1至3期),股骨头髓芯减压术是目前最广泛使用的手术,旨在缓解股骨头内的骨内压并恢复血液供应。对骨坏死发病机制的更深入了解促使人们对该疾病早期阶段的非手术治疗进行研究,包括药物和生物物理治疗。一些非手术治疗后可能会出现症状减轻以及疾病进展得到预防的证据。还需要进一步的研究,包括比较药物治疗与手术干预的试验。